Atlas Trials

Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg

Clinical trial NCT00649818 · COMPLETED

Trial details

NCT number
NCT00649818
Sponsor
Mylan Pharmaceuticals Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2004-12-01
Primary completion
2004-12-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.